Seeing Is Believing
Aimmune Therapeutics's activity chart (see below) currently has 121 price targets and 100 ratings on display.
Analysts average stock forecasts to be materialized ratio is 35.39% with an average time for these price targets to be met of 119.43 days.
Most recent stock forecast was given by from WELLS FARGO on 01-Sep-2020. First documented stock forecast 31-Aug-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Nov-2015
$35
$0.51 (1.48%)
Hold Since 04-Feb-2020
$34.5
$0.01 (0.03%)
Buy Since 14-Jun-2016
$34.5
$0.01 (0.03%)
$66
Buy Since 03-Jun-2019
$60
What is AIMT (Aimmune Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AIMT (Aimmune Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AIMT (Aimmune Therapeutics)?
Which analyst is the currently most bullish on AIMT (Aimmune Therapeutics)?
Which analyst is the currently most reserved on AIMT (Aimmune Therapeutics)?